Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Evogene Ltd. (NASDAQ: EVGN)
EVGN Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
69.50%
Analyst Rating:
NOT AVAILABLE
Analyst Forecast (1yr):
NOT AVAILABLE
EVGN Stock Analysis
EVGN
PE Ratio:
EVGN
PEG Ratio:
Not Available
EVGN
Forward EPS Growth (12 month):
0.00%
EVGN
PS Ratio:
3
EVGN
PSG Ratio:
EVGN
Forward Revenue Growth (12 month):
73.30%
EVGN Articles
No data was found